THIRD POLE

THIRD POLE, INC.

22 Investors
Biotechnology - Cardiopulmonary Therapies
WALTHAM, MA

Third Pole, Inc. is an innovative biotechnology company dedicated to developing and delivering essential life-sustaining therapies for cardiopulmonary conditions. The company specializes in creating portable, tankless inhaled nitric oxide (iNO) delivery systems to enhance accessibility and patient care.

Products & Team

eNOfit™

Portable TherapySeed

eNOfit™ is a miniaturized, wearable device designed for home and travel use that enables patients to receive inhaled nitric oxide therapy conveniently in their daily lives. This device allows for greater patient mobility and independence.

Value Proposition

The eNOfit™ device addresses the challenge of limited access to inhaled nitric oxide therapy outside of hospitals by providing a solution that can be used anywhere, at any time.

Pain Points

Customers face limitations with traditional inhaled nitric oxide therapies, including dependency on bulky compressed gas tanks and restricted therapy access, particularly in home care settings.

Tankless design for portabilityOn-demand nitric oxide generation from air and electricityWearable and user-friendly for patients

Hirak Parikh

Directorat THIRD POLE, INC.
Joined THIRD POLE, INC.
March 2025

Basil Athenson

Company Signatory
Chief Executive Officer and Presidentat THIRD POLE, INC.
Joined THIRD POLE, INC.
March 2025
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
WALTHAM, MA
Primary headquarters

Funding History

Total Raised:
$16.9M
E

Equity, Debt Financing Offering

March 2024
$30.0M
Target
Use of Proceeds
Certain persons named in Item 3 or affiliate(s)thereof may receive payments deemed made from the proceeds of the offering, including management and/or administrative fees. The amounts of such payments cannot be estimated at this time.
Progress
56%
Raised
$16.9M
Target
$30.0M
#000091142025000081